Daniel Auclair: NGS Has Reached a Point Where It Is Better than FISH for Myeloma
Daniel Auclair/X

Daniel Auclair: NGS Has Reached a Point Where It Is Better than FISH for Myeloma

Daniel Auclair, President of Hematocure and Senior Vice President of Business Development at Predicta Biosciences, shared a post on X about a paper by Juan-Jose Garces and Francesco Maura published in Blood:

“Time to say adieu to FISH in myeloma diagnostics. Indeed, NGS (and especially WGS) has reached a point where it is better than FISH and provides so much more information.”

Title: Time to say adieu to FISH in myeloma diagnostics

Authors: Juan-Jose Garces, Francesco Maura

You can read the Full Article in Blood.

Daniel Auclair: NGS Has Reached a Point Where It Is Better than FISH for Myeloma

More posts featuring Daniel Auclair.